Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical and subconjunctival interferon alpha-2b for primary and recurrent pterygium
IRCT20190806044463N1Phase 2Completed
- Sponsor
- Baqiyatallah University of Medical Sciences
- Start
- Sep 2016
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of interferon alfa-2b in pterygium, sponsored by Baqiyatallah University of Medical Sciences. Primary endpoint: Efficacy of topical interferon alpha-2b in primary and recurrent pterygium. Started Sep 2016; status: completed.
02
Drugs
interferon alfa-2b
03
Conditions
pterygium
Beyond the preview
Go deeper on IRCT20190806044463N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190806044463N1.